AbbVie Inc (ABBV)

Gross profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Gross profit (ttm)	US$ in thousands	41,468,000	42,677,000	39,871,000	37,210,000	37,221,000	36,257,000	38,605,000	39,393,000	40,640,000	40,255,000	40,417,000	39,440,000	38,751,000	37,359,000	35,259,000	32,537,000	30,417,000	27,941,000	26,648,000	26,370,000
Revenue (ttm)	US$ in thousands	56,334,000	55,533,000	55,000,000	54,403,000	54,318,000	55,138,000	56,023,000	56,741,000	58,054,000	57,819,000	57,349,000	56,725,000	56,197,000	55,169,000	53,729,000	50,195,000	45,804,000	40,650,000	36,227,000	34,057,000
Gross profit margin		73.61%	76.85%	72.49%	68.40%	68.52%	65.76%	68.91%	69.43%	70.00%	69.62%	70.48%	69.53%	68.96%	67.72%	65.62%	64.82%	66.41%	68.74%	73.56%	77.43%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $41,468,000K ÷ $56,334,000K
= 73.61%

The gross profit margin of AbbVie Inc has exhibited some fluctuations over the periods indicated in the data provided. Starting at 77.43% on March 31, 2020, the gross profit margin gradually declined to its lowest point of 64.82% on March 31, 2021. However, from that point onwards, there was a gradual improvement in the margin, with some fluctuations along the way. The margin peaked at 76.85% on September 30, 2024, before slightly decreasing to 73.61% by December 31, 2024.

Overall, the trend shows that AbbVie Inc has been able to successfully manage its cost of goods sold relative to its revenues, as indicated by the gross profit margin. Despite some fluctuations, the general trajectory of the margin suggests effective cost management and pricing strategies within the company. Further analysis would be needed to understand the specific factors contributing to these changes in the gross profit margin over the periods covered.